Synthesis of 1,2,4-triazole derivatives containing benzothiazoles as pharmacologically active molecule

References

• Stokstad, E. Infectious disease. Drug-resistant TB on the rise. Science 2000, 287, 2391.
   PubMed Web of Science ®Google Scholar
• WHO Global Tuberculosis Programme—Tuberculosis Fact Sheet, 2002. World Health Organization. Global Tuberculosis Control, WHO Report 2001, 2002.
   Google Scholar
• World Health Organization, Geneva, Switzerland, WHO/CDS/TB/2001, 287. http://www.who.int/mediacentre/factsheets/who104/en/index.html
   Google Scholar
• Mooran, N. WHO issues another gloomy tuberculosis report. Nat. Med. 1996, 2, 377.
   PubMed Web of Science ®Google Scholar
• Dye, C., Scheele, S., Dolin, P., Pathania, V., Raviglione, M.C. Global burden of tuberculosis: estimated incidence, prevalence and mortality by country. J. Am. Med. Assoc. 1999, 282, 677–686.
   PubMed Web of Science ®Google Scholar
• Dooley, S.W., Jarvis, W.R., Martone, W.J., Snider, D.E. Jr. Multidrug-resistant tuberculosis. Ann. Intern. Med. 1992, 117, 257–259.
   PubMed Web of Science ®Google Scholar
• Raviglione, M.C., Snider, D.E. Jr, Kochi, A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 1995, 273, 220–226.
   PubMed Web of Science ®Google Scholar
• Farmer, P., Bayona, J., Becerra, M., Furin, J., Henry, C., Hiatt, H., Kim, J.Y., Mitnick, C., Nardell, E., Shin, S. The dilemma of MDR-TB in the global era. Int. J. Tuberc. Lung Dis. 1998, 2, 869–876.
   PubMed Web of Science ®Google Scholar
• Hudson, A., Imamura, T., Gutteridge, W., Kanyok, T., Nunn, P. The Current Anti-TB Drug Research and Development Pipeline. WHO TDR/PRD/03.1W Geneva, 2003.
   Google Scholar
• Tripathi, R.P., Tewari, N., Dwivedi, N., Tiwari, V.K. Fighting tuberculosis: an old disease with new challenges. Med. Res. Rev. 2005, 25, 93–131.
   PubMed Web of Science ®Google Scholar
• Banfi, E., Scialino, G., Zampieri, D., Mamolo, M.G., Vio, L., Ferrone, M., Fermeglia, M., Paneni, M.S., Pricl, S. Antifungal and antimycobacterial activity of new imidazole and triazole derivatives. A combined experimental and computational approach. J. Antimicrob. Chemother. 2006, 58, 76–84.
   PubMed Web of Science ®Google Scholar
• Ulusoy, N., Gürsoy, A., Otük, G. Synthesis and antimicrobial activity of some 1,2,4-triazole-3-mercaptoacetic acid derivatives. Farmaco 2001, 56, 947–952.
   PubMedGoogle Scholar
• Muhi-Eldeen Z, Nadir M, Aljobory NR, Husseen F, Stohs SJ. Synthesis and antimicrobial evaluation of 3-(4-tert-amino-2-butynyl)thio and alkyl/alkenylthio-4,5-disubstituted-4H-1,2,4-triazoles. Eur. J. Med. Chem. 1991, 26, 237–241.
   Web of Science ®Google Scholar
• Küçükgüzel, I., Tatar, E., Küçükgüzel, S.G., Rollas, S., De Clercq, E. Synthesis of some novel thiourea derivatives obtained from 5-[(4-aminophenoxy)methyl]-4-alkyl/aryl-2,4-dihydro-3H-1,2,4-triazole-3-thiones and evaluation as antiviral/anti-HIV and anti-tuberculosis agents. Eur. J. Med. Chem. 2008, 43, 381–392.
   PubMed Web of Science ®Google Scholar
• Banfi, E., Mamolo, M.G., Zampieri, D., Vio, L., Monti Bragadin, C. Antimycobacterial activity of N1-[1-[3-aryl-1-(pyridin-2-, 3- or 4-yl)-3-oxo] propyl]-2-pyridinecarboxamidrazones. J. Antimicrob. Chemother. 2001, 48, 705–707.
   PubMed Web of Science ®Google Scholar
• Jackson, C.J., Lamb, D.C., Kelly, D.E., Kelly, S.L. Bactericidal and inhibitory effects of azole antifungal compounds on Mycobacterium smegmatis. FEMS Microbiol. Lett. 2000, 192, 159–162.
   PubMed Web of Science ®Google Scholar
• Guardiola-Diaz, H.M., Foster, L.A., Mushrush, D., Vaz, A.D. Azole-antifungal binding to a novel cytochrome P450 from Mycobacterium tuberculosis: implications for treatment of tuberculosis. Biochem. Pharmacol. 2001, 61, 1463–1470.
   PubMed Web of Science ®Google Scholar
• McLean, K.J., Marshall, K.R., Richmond, A., Hunter, I.S., Fowler, K., Kieser, T., Gurcha, S.S., Besra, G.S., Munro, A.W. Azole antifungals are potent inhibitors of cytochrome P450 mono-oxygenases and bacterial growth in mycobacteria and streptomycetes. Microbiology 2002, 30, 314–318.
   Google Scholar
• Dabiri, M., Salehi, P., Baghbanzadeh, M., Bahramnejad, M. A facile procedure for the one-pot synthesis of unsymmetrical 2,5-disubstituted 1,3,4-oxadiazoles. Tetrahedron Lett. 2006, 47, 6983–6986.
   Web of Science ®Google Scholar
• Navarrete-Vázquez, G., Molina-Salinas, G.M., Duarte-Fajardo, Z.V., Vargas-Villarreal, J., Estrada-Soto, S., González-Salazar, F., Hernández-Núñez, E., Said-Fernández, S. Synthesis and antimycobacterial activity of 4-(5-substituted-1,3,4-oxadiazol-2-yl)pyridines. Bioorg. Med. Chem. 2007, 15, 5502–5508.
   PubMed Web of Science ®Google Scholar
• Podust, L.M., Poulos, T.L., Waterman, M.R. Crystal structure of cytochrome P450 14alpha-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 3068–3073.
   PubMed Web of Science ®Google Scholar
• Bellamine, A., Mangla, A.T., Nes, W.D., Waterman, M.R. Characterization and catalytic properties of the sterol 14alpha-demethylase from Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 8937–8942.
   PubMed Web of Science ®Google Scholar
• Barnett, C.J. Exchange Amination Process for Preparing 2-Hydrazinobenzothiazoles. U.S. Patent 3,937,714.
   Google Scholar
• Kumar, V., Roy, R.K., Kumar, V., Kukshal, A., Yadav, V.P. Synthesis and antimicrobial activity of 2-(6-substituted-1,3-benzothiazol-2-yl)-N-(4-halophenyl)hydrazinecarbothiomide. J. Indian Chem. Soc. 2008, 85B, 333–335.
   Google Scholar
• Rattan, A. Antimicrobials in Laboratory Medicine. New Delhi: Churchill BI Livingstone, 2000, pp. 85–108.
   Google Scholar
• Anargyros, P., Astill, D.S., Lim, I.S. Comparison of improved BACTEC and Lowenstein-Jensen media for culture of mycobacteria from clinical specimens. J. Clin. Microbiol. 1990, 28, 1288–1291.
   PubMed Web of Science ®Google Scholar
• Shah, R.R., Mehta, R.D., Parikh, A.R. Studies on isoniazide derivatives: preparation and antimicrobial activity of 2-aryl-3-(pyridylcarbomyl)-5-carboxymethyl-4-thiazolidinones. J. Indian Chem. Soc. 1985, 62B, 255–257.
   Google Scholar
• Desai, N.C., Shukla, H.K., Tahker, K.A. Some new 2-aryl-3-isonicotamido-4-thiazolidinones and their 5-carboxymethyl homologues as potential antitubercular and antibacterial agent. J. Indian Chem. Soc. 1984, 61B, 239–240.
   Google Scholar